{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:16:00Z","timestamp":1785446160817,"version":"3.56.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This work was supported by the Medical Innovation and Development Project of Lanzhou University","award":["Grant No. lzuyxcx-2022-105"],"award-info":[{"award-number":["Grant No. lzuyxcx-2022-105"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12033-024-01149-y","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T19:02:31Z","timestamp":1713985351000},"page":"1641-1658","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pan-Cancer Analysis Shows that KIFC2 is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Bladder Cancer"],"prefix":"10.1007","volume":"67","author":[{"given":"Helin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dali","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualan","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9622-9664","authenticated-orcid":false,"given":"Panfeng","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"issue":"3","key":"1149_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209\u2013249.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"1149_CR2","doi-asserted-by":"crossref","first-page":"1287599","DOI":"10.3389\/fchem.2023.1287599","volume":"11","author":"M Naveed","year":"2023","unstructured":"Naveed, M., Ishfaq, H., Rehman, S. U., Javed, A., Waseem, M., Makhdoom, S. I., et al. (2023). GC-MS profiling of Bacillus spp metabolites with an in vitro biological activity assessment and computational analysis of their impact on epithelial glioblastoma cancer genes. Frontiers in Chemistry, 11, 1287599.","journal-title":"Frontiers in Chemistry"},{"key":"1149_CR3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.immunol.25.022106.141609","volume":"25","author":"GA Rabinovich","year":"2007","unstructured":"Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007). Immunosuppressive strategies that are mediated by tumor cells. Annual Review of Immunology, 25, 267\u2013296.","journal-title":"Annual Review of Immunology"},{"issue":"11","key":"1149_CR4","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/ni1102-999","volume":"3","author":"HT Khong","year":"2002","unstructured":"Khong, H. T., & Restifo, N. P. (2002). Natural selection of tumor variants in the generation of \u201ctumor escape\u201d phenotypes. Nature Immunology, 3(11), 999\u20131005.","journal-title":"Nature Immunology"},{"issue":"5","key":"1149_CR5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","volume":"8","author":"DA Thomas","year":"2005","unstructured":"Thomas, D. A., & Massagu\u00e9, J. (2005). TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell, 8(5), 369\u2013380.","journal-title":"Cancer Cell"},{"issue":"8","key":"1149_CR6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., & Zhang, Z. (2020). The history and advances in cancer immunotherapy: Understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cellular & Molecular Immunology, 17(8), 807\u2013821.","journal-title":"Cellular & Molecular Immunology"},{"issue":"3","key":"1149_CR7","first-page":"599","volume":"70","author":"S Akash","year":"2023","unstructured":"Akash, S., Rahman, M. M., Gon\u00e7alves-Lima, C. M., Emran, T. B., Sultana, S., Naz, S., et al. (2023). Design and development of new inhibitors against breast cancer, Monkeypox and Marburg virus by modification of natural Fisetin via in silico and SAR studies. Acta Biochimica Polonica, 70(3), 599\u2013600.","journal-title":"Acta Biochimica Polonica"},{"issue":"3","key":"1149_CR8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1142\/S2737416523500643","volume":"23","author":"N Muhammad","year":"2024","unstructured":"Muhammad, N., Hamza, J., Tariq, A., Syeda Izma, M., Abdulhakeem-S, A., Majid, A., et al. (2024). Spatially resolved transcriptomics reveals local invasion-related genes in liver hepatocellular carcinoma: exploring the therapeutic potential of a chimeric protein targeting glypican-3. Journal of Computational Biophysics and Chemistry, 23(3), 321\u2013332.","journal-title":"Journal of Computational Biophysics and Chemistry"},{"key":"1149_CR9","doi-asserted-by":"publisher","DOI":"10.1242\/dev.200231","author":"MM Shan","year":"2022","unstructured":"Shan, M. M., Zou, Y. J., Pan, Z. N., Zhang, H. L., Xu, Y., Ju, J. Q., et al. (2022). Kinesin motor KIFC1 is required for tubulin acetylation and actin-dependent spindle migration in mouse oocyte meiosis. Development. https:\/\/doi.org\/10.1242\/dev.200231","journal-title":"Development"},{"issue":"7","key":"1149_CR10","doi-asserted-by":"crossref","first-page":"100134","DOI":"10.1016\/j.labinv.2023.100134","volume":"103","author":"BY Yu","year":"2023","unstructured":"Yu, B. Y., Shi, L. G., Jiang, C., Wang, G. K., Liu, J., & Wu, T. Y. (2023). Kinesin family member C1 overexpression exerts tumor-promoting properties in head and neck squamous cell carcinoma via the Rac1\/Wnt\/\u03b2-catenin pathway. Laboratory Investigation: A Journal of Technical Methods and Pathology, 103(7), 100134.","journal-title":"Laboratory Investigation: A Journal of Technical Methods and Pathology"},{"issue":"1","key":"1149_CR11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41467-020-20208-x","volume":"12","author":"G Fan","year":"2021","unstructured":"Fan, G., Sun, L., Meng, L., Hu, C., Wang, X., Shi, Z., et al. (2021). The ATM and ATR kinases regulate centrosome clustering and tumor recurrence by targeting KIFC1 phosphorylation. Nature Communications, 12(1), 20.","journal-title":"Nature Communications"},{"key":"1149_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8020225","author":"Y Sekino","year":"2019","unstructured":"Sekino, Y., Oue, N., Koike, Y., Shigematsu, Y., Sakamoto, N., Sentani, K., et al. (2019). KIFC1 inhibitor CW069 induces apoptosis and reverses resistance to docetaxel in prostate cancer. Journal of Clinical Medicine. https:\/\/doi.org\/10.3390\/jcm8020225","journal-title":"Journal of Clinical Medicine"},{"issue":"3","key":"1149_CR13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41388-018-0440-8","volume":"38","author":"J Han","year":"2019","unstructured":"Han, J., Wang, F., Lan, Y., Wang, J., Nie, C., Liang, Y., et al. (2019). KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin\/AKT signaling. Oncogene, 38(3), 406\u2013420.","journal-title":"Oncogene"},{"issue":"7","key":"1149_CR14","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.4251\/wjgo.v14.i7.1239","volume":"14","author":"WW Hao","year":"2022","unstructured":"Hao, W. W., & Xu, F. (2022). KIFC3 promotes proliferation, migration and invasion of esophageal squamous cell carcinoma cells by activating EMT and \u03b2-catenin signaling. World Journal of Gastrointestinal Oncology, 14(7), 1239\u20131251.","journal-title":"World Journal of Gastrointestinal Oncology"},{"key":"1149_CR15","volume":"13","author":"H Liao","year":"2022","unstructured":"Liao, H., Zhang, L., Lu, S., Li, W., & Dong, W. (2022). KIFC3 promotes proliferation, migration, and invasion in colorectal cancer via PI3K\/AKT\/mTOR signaling pathway. Frontiers in Genetics, 13, 848926.","journal-title":"Frontiers in Genetics"},{"issue":"9","key":"1149_CR16","first-page":"1270","volume":"55","author":"Y He","year":"2023","unstructured":"He, Y., He, P., Lu, S., & Dong, W. (2023). KIFC3 Regulates the progression and metastasis of gastric cancer via Notch1 pathway. Digestive and Liver Disease, Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 55(9), 1270\u20131279.","journal-title":"Digestive and Liver Disease, Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver"},{"issue":"11","key":"1149_CR17","volume":"299","author":"X Liu","year":"2023","unstructured":"Liu, X., Lin, Y., Long, W., Yi, R., Zhang, X., Xie, C., et al. (2023). The kinesin-14 family motor protein KIFC2 promotes prostate cancer progression by regulating p65. The Journal of Biological Chemistry, 299(11), 105253.","journal-title":"The Journal of Biological Chemistry"},{"issue":"43","key":"1149_CR18","volume":"102","author":"T Chen","year":"2023","unstructured":"Chen, T., Chu, Y., Xu, H., Dai, H., Zhou, Y., Du, H., et al. (2023). Kinesin superfamily member KIFC2 as an independent prognostic biomarker of colon adenocarcinoma associated with poor immune response. Medicine, 102(43), e35491.","journal-title":"Medicine"},{"issue":"3","key":"1149_CR19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0896-6273(00)81243-X","volume":"18","author":"N Saito","year":"1997","unstructured":"Saito, N., Okada, Y., Noda, Y., Kinoshita, Y., Kondo, S., & Hirokawa, N. (1997). KIFC2 is a novel neuron-specific C-terminal type kinesin superfamily motor for dendritic transport of multivesicular body-like organelles. Neuron, 18(3), 425\u2013438.","journal-title":"Neuron"},{"issue":"3","key":"1149_CR20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0896-6273(00)81244-1","volume":"18","author":"DW Hanlon","year":"1997","unstructured":"Hanlon, D. W., Yang, Z., & Goldstein, L. S. (1997). Characterization of KIFC2, a neuronal kinesin superfamily member in mouse. Neuron, 18(3), 439\u2013451.","journal-title":"Neuron"},{"issue":"1","key":"1149_CR21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12943-022-01671-0","volume":"21","author":"QF Han","year":"2022","unstructured":"Han, Q. F., Li, W. J., Hu, K. S., Gao, J., Zhai, W. L., Yang, J. H., et al. (2022). Exosome biogenesis: Machinery, regulation, and therapeutic implications in cancer. Molecular Cancer, 21(1), 207.","journal-title":"Molecular Cancer"},{"key":"1149_CR22","volume":"9","author":"Y Cao","year":"2021","unstructured":"Cao, Y., Jiao, N., Sun, T., Ma, Y., Zhang, X., Chen, H., et al. (2021). CXCL11 Correlates With Antitumor Immunity and an Improved Prognosis in Colon Cancer. Frontiers in Cell and Developmental Biology, 9, 646252.","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"1149_CR23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejca.2022.05.022","volume":"171","author":"Z Liu","year":"2022","unstructured":"Liu, Z., Jin, K., Zeng, H., Shao, F., Chang, Y., Wang, Y., et al. (2022). B7\u2013H4 correlates with clinical outcome and immunotherapeutic benefit in muscle-invasive bladder cancer. European Journal of Cancer, 171, 133\u2013142.","journal-title":"European Journal of Cancer"},{"issue":"9","key":"1149_CR24","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/eji.201141477","volume":"41","author":"TJ Slebioda","year":"2011","unstructured":"Slebioda, T. J., Rowley, T. F., Ferdinand, J. R., Willoughby, J. E., Buchan, S. L., Taraban, V. Y., et al. (2011). Triggering of TNFRSF25 promotes CD8+ T-cell responses and anti-tumor immunity. European Journal of Immunology, 41(9), 2606\u20132611.","journal-title":"European Journal of Immunology"},{"key":"1149_CR25","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun, Y., Sedgwick, A. J., Khan, M. A., Palarasah, Y., Mangiola, S., & Barrow, A. D. (2021). A Transcriptional Signature of IL-2 Expanded Natural Killer Cells Predicts More Favorable Prognosis in Bladder Cancer. Frontiers in Immunology, 12, 724107.","journal-title":"Frontiers in Immunology"},{"key":"1149_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003667","author":"Y Wang","year":"2022","unstructured":"Wang, Y., Wang, C., Qiu, J., Qu, X., Peng, J., Lu, C., et al. (2022). Targeting CD96 overcomes PD-1 blockade resistance by enhancing CD8+ TIL function in cervical cancer. Journal for Immunotherapy of Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-003667","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"3","key":"1149_CR27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning, B. D., & Toker, A. (2017). AKT\/PKB signaling: navigating the network. Cell, 169(3), 381\u2013405.","journal-title":"Cell"},{"issue":"1","key":"1149_CR28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13045-021-01137-8","volume":"14","author":"H Hua","year":"2021","unstructured":"Hua, H., Zhang, H., Chen, J., Wang, J., Liu, J., & Jiang, Y. (2021). Targeting Akt in Cancer for Precision Therapy. Journal of Hematology & Oncology, 14(1), 128.","journal-title":"Journal of Hematology & Oncology"},{"issue":"1","key":"1149_CR29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00048.2019","volume":"101","author":"G Biffi","year":"2021","unstructured":"Biffi, G., & Tuveson, D. A. (2021). Diversity and biology of cancer-associated fibroblasts. Physiological Reviews, 101(1), 147\u2013176.","journal-title":"Physiological Reviews"},{"issue":"2","key":"1149_CR30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","volume":"2","author":"B Huang","year":"2020","unstructured":"Huang, B., Song, B. L., & Xu, C. (2020). Cholesterol metabolism in cancer: Mechanisms and therapeutic opportunities. Nature Metabolism, 2(2), 132\u2013141.","journal-title":"Nature Metabolism"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01149-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-024-01149-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01149-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T01:34:31Z","timestamp":1742693671000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-024-01149-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1149"],"URL":"https:\/\/doi.org\/10.1007\/s12033-024-01149-y","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]},"assertion":[{"value":"5 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study received the Lanzhou University Second Hospital Ethical Committee approval. The project name is the role and mechanism study of KIFC2 in bladder cancer, with project number 2023A-800, and was passed on December 12, 2023. We have obtained written informed consent from all patients or their families for our clinical studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}